III期ReSPECT研究已完成入组，该研究旨在预防接受异基因血液和骨髓移植的成人患者发生真菌感染 ReSPECT研究的主要结果预计将于2026年中期公布 英国剑桥--(BUSINESS WIRE)--(美国商业资讯)-- Mundipharma今日宣布，正在进行的全球III期ReSPECT试验已完成患者招募，该试验 ...

Latest analysis of U.S. real-world evidence demonstrates improved clinical outcomes when cefiderocol is used as earlier ...

The field hockey star uses the sam® sustained acoustic medicine device from ZetrOZ Systems to manage knee osteoarthritis, ...

Management to Showcase Full Nature-Cide Product Line at Industry's Flagship Event LOS ANGELES, CA / ACCESS Newswire / October ...

Five-year strategy positions the iconic Lifeline brand to reach one million older adults through a connected healthcare ...

Rhythio Medical’s soft, conductive hydrogel technology transforms traditional defibrillation into a new class of injectable bioelectronic therapyHOUSTON--(BUSINESS WIRE)--Rhythio Medical, a medical ...

Prolong Pharmaceuticals, LLC (the Company), a clinical-stage biopharmaceutical company, today announced that it will present key clinical data from HEMERA-1, its Phase 1/2 clinical trial in Acute ...

Zoliflodacin, an investigational single-dose oral antibiotic for uncomplicated gonorrhea, to be featured in oral presentation ...

New $25 million raise advances multi-node PI3K program; randomized phase 2 trial with Gynecologic Oncology Group Foundation now enrollingAUSTIN, Texas--(BUSINESS WIRE)--Faeth Therapeutics, a ...

KIVU-107 is the first PTK7-targeting ADC with a DAR4 exatecan payload, engineered for exceptional stability and highly selective on-tumor delivery.Preclinical data demonstrate deeper and durable ...

Funding accelerates development of novel therapeutics to improve outcomes for patients with cancerCAMBRIDGE, Mass. & LONDON--(BUSINESS WIRE)--#ADC--Valink Therapeutics Inc. (“Valink”), a private ...

Company launches the first-of-its-kind, AI-powered clinical trial feasibility platform to accelerate clinical trial startup – ...